Clinical Trial Update: Clinical Trial to Evaluate Efficacy and Safety of Dupilumab in Localized Scleroderma [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study evaluating the efficacy and safety of dupilumab in localized scleroderma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Localized Scleroderma

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: University of Cologne | Conditions: Localized Scleroderma | Phase 2 | Status: COMPLETED